|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 404.46 USD | -2.59% |
|
-14.54% | +71.88% |
| 12-03 | Alnylam Pharmaceuticals Announces Changes to Board of Directors | CI |
| 12-03 | Alnylam Pharmaceuticals announces changes to board of directors | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.85B | |||||
| 879B | |||||
| 482B | |||||
| 394B | |||||
| 335B | |||||
| 281B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition